Holland Bloorview Kids Rehabilitation Hospital is leading a groundbreaking national precision health initiative for children and youth, focusing on neurodevelopmental conditions, mental health, and brain injuries12. This initiative is part of the larger Canadian Precision Health Initiative (CPHI), which aims to build Canada’s largest-ever collection of human genomic data12. The project at Holland Bloorview will…
The U.S. Food and Drug Administration (FDA) has granted clearance for Defloria Pharmaceuticals to proceed with a Phase 2 clinical trial of its cannabis-based treatment for autism spectrum disorder (ASD). This development marks a significant step forward in exploring the potential of cannabis-derived compounds for managing autism symptoms. Defloria’s investigational new drug, DFLO-001, is specifically…
In a significant development in the Bryan Kohberger case, the defense team has brought autism spectrum disorder (ASD) to the forefront of their legal strategy. Kohberger, accused of murdering four University of Idaho students in 2022, now faces a new dimension in his legal battle as his attorneys argue that his ASD diagnosis should preclude…
In a contentious Senate confirmation hearing on March 5, 2025, Dr. Jay Bhattacharya, President Donald Trump’s nominee to lead the National Institutes of Health (NIH), ignited a firestorm of debate with his comments on vaccine safety and autism research. Bhattacharya, a Stanford University professor of medicine, expressed openness to funding new studies exploring potential links…
